PBI
35
-3
AAP
8
-4
XEL
39
-5
APH
48
-2
CI
45
-13
ADM
16
-4
GILD
55
-3
JNPR
52
-2
NVDA
33
-2
MO
53
-3
MOS
19
-3
GIS
32
-3
PPG
22
-5
HBAN
45
-2
APD
20
-4
ZBH
44
-3
AVY
37
-4
NKE
6
-2
QCOM
31
-4
ABBV
30
-5
PBI
35
-3
AAP
8
-4
XEL
39
-5
APH
48
-2
CI
45
-13
ADM
16
-4
GILD
55
-3
JNPR
52
-2
NVDA
33
-2
MO
53
-3
MOS
19
-3
GIS
32
-3
PPG
22
-5
HBAN
45
-2
APD
20
-4
ZBH
44
-3
AVY
37
-4
NKE
6
-2
QCOM
31
-4
ABBV
30
-5
Financhill
Back

Swedbank AB Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
29

SWDBY
Swedbank AB

Last Price:
$21.30
Seasonality Move:
4.29%
Sell
46

SRPT
Sarepta Therapeutics

Last Price:
$55.58
Seasonality Move:
15.14%
Sell
29
Swedbank AB (SWDBY) is a Sell

Is Swedbank AB a Buy, Sell or Hold?

  • The current Swedbank AB [SWDBY] share price is $19.58. The Score for SWDBY is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • SWDBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $49.30. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SWDBY Stock Price Chart

What is Swedbank AB's stock price today?

  • The Swedbank AB share price today is $19.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWDBY is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $49.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

SWDBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.05 Sell
Relative Strength Index (14 RSI): 21.73 Sell
Chaikin Money Flow: -98411 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.38 - 26.62) Sell
Bollinger Bands (100): (19.6 - 24.22) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.75 Sell
Relative Strength Index (14 RSI): 17.62 Sell
Chaikin Money Flow: -3152081 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.02 - 97.84) Sell
Bollinger Bands (100): (87.89 - 128.09) Sell

SWDBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.72 Sell
20-day SMA: 24.23 Sell
50-day SMA: 23.8 Sell
200-day SMA: 21.28 Sell
8-day EMA: 21.6 Sell
20-day EMA: 23.2 Sell
50-day EMA: 23.35 Sell
200-day EMA: 21.63 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.17 Sell
20-day SMA: 73.29 Sell
50-day SMA: 95.05 Sell
200-day SMA: 121.65 Sell
8-day EMA: 58.65 Sell
20-day EMA: 71.2 Sell
50-day EMA: 89.01 Sell
200-day EMA: 112.2 Sell

Swedbank AB Earnings Growth & SWDBY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.47 per share, and an increase next year of $0.07 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.39 per share, a decrease next quarter of $0.51 per share, an increase this year of $5.06 per share, and an increase next year of $5.37 per share.

Swedbank AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):